间歇性跛行最大步行距离的最有效运动处方:系统评价与网络荟萃分析
结果显示,可能的最优处方为:间歇性步行、每周3次、基于疼痛的处方(从无痛或疼痛起始至最大疼痛)、每次30-60分钟、持续12周(中等至高质量证据)。
要点
- 间歇性步行、每周3次、基于疼痛的处方、每次30-60分钟、持续12周可能最优。
- 该处方基于中等至高质量证据,可指导未来指南与临床实践。
- 原计划组件网络荟萃分析因假设不满足而改用替代分析。
核心结论
- 研究识别出间歇性跛行患者可能的最优监督运动处方,应指导未来指南、临床实践和临床试验。
研究设计与样本
- 系统评价与网络荟萃分析,检索CENTRAL、MEDLINE、Embase、CINAHL、试验注册库和Web of Science。
- 纳入比较监督运动 programme 与适当非侵入性对照或另一种监督运动 programme 的随机对照试验。
主要发现
- 可能的最优监督运动处方为间歇性步行,每周3次,基于疼痛的处方(从无痛或疼痛起始至最大疼痛),每次30-60分钟,持续12周(中等至高质量证据)。
关键数值与推荐
- 最优处方:间歇性步行,每周3次,基于疼痛的处方(从无痛或疼痛起始至最大疼痛),每次30-60分钟,持续12周。
临床怎么用
- 临床可参考该处方为间歇性跛行患者制定监督运动方案,以改善最大步行距离。
局限性
- 组件网络荟萃分析的有效性假设被违反,需采用替代主要分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Supervised exercise programmes are first line treatment for patients with intermittent claudication. Their prescription comprises a combination of components, namely frequency, intensity, time, and type of exercise. However, the optimal prescription (i.e., the most effective combination of these components) remains unknown. This leads to a paucity of comprehensive programme guidelines, poor programme provision, uptake, and completion rates, and potentially ineffective programmes. The aim of this systematic review with network and component network meta-analyses was to identify evidence for the optimal supervised exercise prescription for patients with intermittent claudication. DATA SOURCES: CENTRAL, MEDLINE, Embase, CINAHL, trial registries, and Web of Science. REVIEW METHODS: Randomised controlled trials of patients with intermittent claudication comparing a supervised exercise programme with an appropriate, non-invasive comparator group, or another alternative supervised exercise programme were included. The primary outcome was mean difference in maximum walking distance between the exercise and control groups. A component network meta-analysis was planned to identify the most effective combination of components. However, the assumption required for a valid component network meta-analysis was violated, requiring alternative primary analyses. This involved initially grouping trials by their common components and undertaking standard network meta-analyses for each group to identify the likely effective levels (e.g., once or twice per week). These results were supported by other analyses to identify a likely optimal prescription. RESULTS: Searches returned 13 714 unique results. Sixty four trials (n = 3 427) were included in the primary analysis. The likely optimal supervised exercise prescription is intermittent walking, performed three times a week, using a pain based prescription (ranging from pain free or pain onset to maximum pain) for 30 - 60 minutes per session, for a period of 12 weeks (moderate to high quality evidence). CONCLUSION: This study identified the likely optimal supervised exercise prescription for patients with intermittent claudication, which should inform future guidelines, clinical practice, and clinical trials.
引用
- Prosser J, Huang C, Duarte A, et al. Identifying the Most Clinically Effective Exercise Prescription for Improving Maximum Walking Distance in People with Intermittent Claudication (MAXIMISE): A Systematic Review with Network and Component Network Meta-analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 42379346. doi:10.1016/j.ejvs.2026.06.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。